Overview

Comparison Between Recombinant Versus Urinary hCG for Ovulation Induction in High Responders

Status:
Unknown status
Trial end date:
2016-07-01
Target enrollment:
0
Participant gender:
Female
Summary
The purpose of this study is to compare the clinical outcomes of recombinant human chorionic gonadotrophin (rHCG) and urinary HCG (uHCG) in patients undergoing IVF cycles.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Eugonia
Treatments:
Chorionic Gonadotropin
Criteria
Inclusion Criteria:

- At least 14 follicles >11mm on the day of triggering final oocyte maturation

- Pretreated with GnRH antagonist protocol

Exclusion Criteria:

- Poor responders

- Women with 25 or more follicles on the day of trigger